<DOC>
	<DOCNO>NCT02393066</DOCNO>
	<brief_summary>This single-blind randomized clinical trial . Patients undergoing abdominal tumor surgery recruit participate study . Apart routine treatment surgical intensive care unit , subject randomly divide two group : Propofol group ( Group P ) Dexmedetomidine group ( Group D ) receive continuous intravenous infusion Propofol ( infusion dosage range : 0.3 ~ 1.6 mg/kg/h ) Dexmedetomidine ( infusion dosage range : 0.1 ~ 0.7 mcg/kg/h ) accord assign group . Patients ' hemodynamic status monitor use chest Bioreactance technique , Continuous Non-Invasive Cardiac Output Hemodynamic Monitor preset time point ( time recruitment [ 0h ] , 2 , 4 , 6 , 12h 24h ) . Clinical data vital sign , hemodynamic parameter , laboratory result , fluid volume drug use also record .</brief_summary>
	<brief_title>Comparison Hemodynamics Between Dexmedetomidine Propofol Sedation Patients With Abdominal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>nonemergent major abdominal tumor surgery ICU admission need sedation ICU stay age old 99 year age young 20 year refractory arrhythmias refractory shock status resuscitation new onset myocardial infarction severe heart failure NYHA 4 APACHE score &gt; 30 recruiting severe liver cirrhosis CHILD B C organ transplantation within one year pregnancy allergic propofol dexmedetomidine</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>